ORBIMED ADVISORS LLC
Director, 10% Owner
16 filings on record here, covering BRVE, PRMB, SCTX, EEX, CUEN, SION, ELVN, STTK. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
| Convert | BRVE | Braveheart Bio, Inc. | |
| Buy | BRVE | Braveheart Bio, Inc. | $30,000,006 |
| Buy | BRVE | Braveheart Bio, Inc. | $4,919,994 |
| Convert | BRVE | Braveheart Bio, Inc. | |
CORPORATEFiled 2026-08-10
| Sell | PRMB | Primo Brands Corp | $497,399,986 |
CORPORATEFiled 2026-08-03
CORPORATEFiled 2026-07-29
| Convert | SCTX | Scribe Therapeutics, Inc. | |
| Buy | SCTX | Scribe Therapeutics, Inc. | $15,000,000 |
| Convert | SCTX | Scribe Therapeutics, Inc. | |
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-14
| Disposed | EEX | Emerald Holding, Inc. | |
CORPORATEFiled 2026-07-08
| Buy | CUEN | Cuentas Inc. | $1,108 |
CORPORATEFiled 2026-07-08
CORPORATEFiled 2026-07-06
| Buy | CUEN | Cuentas Inc. | $935 |
| Buy | CUEN | Cuentas Inc. | $846 |
CORPORATEFiled 2026-07-02
| Sell | SION | Sionna Therapeutics, Inc. | $5,270,902 |
CORPORATEFiled 2026-06-30
| Buy | CUEN | Cuentas Inc. | $348 |
| Buy | CUEN | Cuentas Inc. | $306 |
| Buy | CUEN | Cuentas Inc. | $899 |
| Buy | CUEN | Cuentas Inc. | $210 |
| Buy | CUEN | Cuentas Inc. | $555 |
CORPORATEFiled 2026-06-24
| Sell | ELVN | Enliven Therapeutics, Inc. | $1,127,511 |
| Sell | ELVN | Enliven Therapeutics, Inc. | $66,465 |
| Sell | ELVN | Enliven Therapeutics, Inc. | $35,715,149 |
| Sell | ELVN | Enliven Therapeutics, Inc. | $2,104,920 |
CORPORATEFiled 2026-06-23
| Buy | CUEN | Cuentas Inc. | $874 |
| Buy | CUEN | Cuentas Inc. | $70 |
| Buy | CUEN | Cuentas Inc. | $175 |
| Buy | CUEN | Cuentas Inc. | $35 |
| Buy | CUEN | Cuentas Inc. | $36 |
| Buy | CUEN | Cuentas Inc. | $36 |
CORPORATEFiled 2026-06-18
| Buy | CUEN | Cuentas Inc. | $2,700 |
| Buy | CUEN | Cuentas Inc. | $290 |
| Buy | CUEN | Cuentas Inc. | $300 |
| Buy | CUEN | Cuentas Inc. | $1,113 |
CORPORATEFiled 2026-06-17
| Sell | ELVN | Enliven Therapeutics, Inc. | $409,052 |
| Sell | ELVN | Enliven Therapeutics, Inc. | $12,259,936 |
CORPORATEFiled 2026-06-15
| Buy | STTK | Shattuck Labs, Inc. | |
| Buy | STTK | Shattuck Labs, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.